NASDAQ:INO   Inovio Pharmaceuticals, Inc.
As a disclosure I am quite new to reading charts, but i have been learning. In this chart you can see that the consolidation of the highs and lows are funneling towards $13 a share. But keep in mind that a failing testing procedure can break the lows into a new support line. As the earnings are coming up, we may find a price rally.
免責事項

これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。